2022
DOI: 10.3390/diagnostics12051051
|View full text |Cite
|
Sign up to set email alerts
|

Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients

Abstract: Background: Detection of BCR-ABL1 transcript level via real-time quantitative-polymerase-chain reaction (Q-PCR) is a clinical routine for disease monitoring, assessing Tyrosine Kinase Inhibitor therapy efficacy and predicting long-term response in chronic myeloid leukemia (CML) patients. For valid Q-PCR results, each stage of the laboratory procedures need be optimized, including the cell-counting method that represents a critical step in obtaining g an appropriate amount of RNA and reliable Q-PCR results. Tra… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 39 publications
0
2
0
Order By: Relevance
“…Cell processing applications require cell counts at various stages, which are used to make decisions regarding cell health and seeding, amounts of reagents for viral and non-viral modification, dosing, and analytical evaluation. The cell counting methods evaluated here represent a small fraction of the instruments and methods currently on the market (Cadena-Herrera et al, 2015;Camacho-Fernández et al, 2018;Patel et al, 2022;Stella et al, 2022). As new methods become available, it is critical for researchers to perform proper evaluation of the cell counting measurement process (including instruments, reagents and data analysis procedures) to ensure that sources of variability in the counting method do not lead to errors in the production or use of therapeutic products.…”
Section: Discussionmentioning
confidence: 99%
“…Cell processing applications require cell counts at various stages, which are used to make decisions regarding cell health and seeding, amounts of reagents for viral and non-viral modification, dosing, and analytical evaluation. The cell counting methods evaluated here represent a small fraction of the instruments and methods currently on the market (Cadena-Herrera et al, 2015;Camacho-Fernández et al, 2018;Patel et al, 2022;Stella et al, 2022). As new methods become available, it is critical for researchers to perform proper evaluation of the cell counting measurement process (including instruments, reagents and data analysis procedures) to ensure that sources of variability in the counting method do not lead to errors in the production or use of therapeutic products.…”
Section: Discussionmentioning
confidence: 99%
“…The haemoglobin (Hb) concentration was determined according to the method described by using cyanomethaemoglobin. The mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH) and mean corpuscular haemoglobin concentration (MCHC) were determined on the basis of the formulae of [ 31 ].…”
Section: Data Collectionmentioning
confidence: 99%